Lv3
280 积分 2021-10-27 加入
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial
3天前
已完结
The Effects of Sacubitril/Valsartan Compared to Olmesartan on the Blood Pressure and Glucolipid Metabolism in DM Patients with Primary Hypertension
3天前
已完结
中国部分省市糖尿病足病临床资料和住院费用等比较
1个月前
已完结
SGLT-2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials
1个月前
已完结
Efficacy and safety of dapagliflozin in patients with heart failure with mildly reduced or preserved ejection fraction by baseline glycaemic status (DELIVER): a subgroup analysis from an international, multicentre, double-blind, randomised, placebo-controlled trial
1个月前
已完结
First-line atezolizumab monotherapy versus single-agent chemotherapy in patients with non-small-cell lung cancer ineligible for treatment with a platinum-containing regimen (IPSOS): a phase 3, global, multicentre, open-label, randomised controlled study
1个月前
已完结
Global burden of cardiovascular diseases: projections from 2025 to 2050
2个月前
已完结
Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure
2个月前
已完结
Effect of empagliflozin on exercise ability and symptoms in heart failure patients with reduced and preserved ejection fraction, with and without type 2 diabetes
2个月前
已完结
皖公网安备34019202002308
